You are here: Industry Insights > Stem Cell

News List

MIMETAS Launches Ready-to-Use 3D Adult Stem Cell Organoid Tubules PharmaSources
March 08, 2023
MIMETAS,a leading company in the field of organ-on-a-chip-based disease models, announces that it has launched its Adult Stem Cell (ASC)-derived tubular organoids in an assay-ready format.
Experts call for improved oversight to combat rise of unproven stem cell therapies europeanpharmaceuticalreview
June 10, 2021
Stem cell therapy authorities urge the WHO to create an advisory committee for regenerative medicine and work to combat the rising use of unproven stem cell therapies worldwide.
Restrictions Eased on Use of Embryos in Research drugs
May 31, 2021
An international standard that limits how long human embryos can be grown in a laboratory has been extended under limited conditions, which will remove a barrier to stem cell research.
International Society for Stem Cell Research (ISSCR) releases new guidelines europeanpharmaceuticalreview
May 28, 2021
The ISSCR has released updated guidelines for stem cell research and clinical translation of stem cell-based therapies.
FDA approves IND for PSC’s stem cell therapy candidate for Covid-19 pharmaceutical-business-review
August 06, 2020
Calidi Biotherapeutics said that the Investigational New Drug (IND) application submitted by its partner, Personalized Stem Cells, Inc. (PSC), has received FDA approval for the treatment of COVID-19 and pneumonia patients using stem cell therapy.
Second patient cured of HIV using stem cell therapy europeanpharmaceuticalreview
March 12, 2020
Researchers report that a patient who underwent stem-cell transplantation and a chemotherapy drug regimen has been cured of HIV.
Stempeutics partners with Kemwell for global development and commercialisation of stem cell… expresspharma
July 30, 2019
Stempeutics Research has announced that it has signed a strategic deal with Kemwell Biopharma for global commercialisation of its stem cell product Stempeucel.
FDA Releases Statement on Stem Cell Clinic Permanent injunction Against Unapproved Products americanpharmaceuticalreview
June 27, 2019
Statement from Norman E. "Ned" Sharpless MD, Acting Commissioner and Dr. Peter Marks M.D. PhD., Director - Center for Biologics Evaluation and Research (CBER)
Autologous Stem Cell Transplant May Aid Some With Nodal PTCL drugs
February 14, 2019
Autologous stem cell transplantation (ASCT) may be beneficial for some patients with nodal peripheral T-cell lymphoma (PTCL) in the first complete remission (CR1), according to a study published online Jan. 29 in Cancer....
Daiichi Sankyo takes option on diabetes stem cell start-up pharmaphorum
January 14, 2019
Japan’s Daiichi Sankyo has joined an open innovation research initiative that will try to develop a therapy for type 1 diabetes based on insulin-producing cells.

Previous page 1 2 3 Next page